Cancer researchers at Fox Chase Cancer Center see promise in personalized medicine to help crack the code on improving diagnosis and treatment options for pancreatic cancer.
The FDA approved a new cancer treatment called Bizengri for adults with certain types of lung and pancreatic cancers. The approval is the first for a treatment designed for cancers with an NRG1 gene ...